Lacktman Quoted on Remote Prescription Expansion

11 May 2017 Bloomberg BNA News
Partner Nate Lacktman was quoted in a Bloomberg BNA article, “Telemedicine Providers Anticipating Changes to Remote Prescribing Rules,” covering the expansion of allowed remote prescriptions of controlled substances.

“We expect the Drug Enforcement Administration (DEA) to release that rule sooner rather than later,” Lacktman said.

He also explained that although there are an increasing amount of states changing their laws to align with remote prescriptions, “some states, in an attempt to reconcile the provisions of the Ryan Haight Act with their own laws, are building the terms of the federal statute directly into their state regulations.” He warned against this practice because it ultimately might not benefit the patients.

Related Services

Insights

Text Messages, EDiscovery, and the New Threat to Privacy
21 November 2019
CMS Proposes Enhanced Scrutiny over Medicaid Supplemental Payments
20 November 2019
Health Care Law Today
The Purpose of a Corporation
November 2019
Legal News: Business Law
Should This Be a "Mobility" Industry Blog?
19 November 2019
Dashboard Insights
PATH Summit 2019
18-20 December 2019
Arlington, VA
Madison CLE Days
18-19 December 2019
Madison, WI
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
HFMA MA-RI Annual Compliance Update
12 December 2019
Boston, MA